Sign Up
OverviewAPI
Humana's stock plummeted due to poor earnings guidance, driven by soaring medical costs, impacting the broader insurance industry. The company's full-year earnings forecast for 2024 is significantly lower than analysts' estimates, leading to a 37% stock decline. Humana's medical benefit ratio for the fourth quarter was 90.7%, resulting in a loss of $591 million compared to the previous year.

Ask a question